Rare side effect after J&J vaccine. 6 cases of blood clot called cerebral venous sinus thrombosis (CVST) among women between the ages of 18-48, with symptoms between 6-13 days after vaccination. Out of 6.8 million doses given (0.00009%). U.S. pausing statnews.com/2021/04/13/u-s…
222 cases of CVST out of 34 million people with AztraZeneca vaccine reported as well (0.00006%), most cases in women under 55 years. Of note, both J&J vaccine and AZ vaccine are adenovirus vaccines with DNA coding for spike protein inside them.
sciencemag.org/news/2021/04/h…
Both extremely rare (0.0000006-0.000009) so please first keep that in mind. Postulated mechanism here - syndrome called vaccination immune thrombotic thrombocytopenia (VITT). All patients with low platelets (thrombocytopenia) & unusual clots (thrombosis).
nejm.org/doi/full/10.10…
Vaccine seems to trigger platelet factor 4 (PF4)–heparin antibodies; something we rarely see heparin (a blood thinner) do- trigger these antibodies. Known that adenovirus can bind to platelets & cause platelet activation; leads to both low platelets & some to clump (clot)
Alternatively, possible trigger of these PF4-reactive antibodies could be free DNA in vax. Can diagnosis with anti-PF4 antibodies. Very rare; don't worry if you have already received J&J; CDC & FDA recommending halting J&J for now while being investigated; sorry to report this
Extremely rare side effects; seems to be restricted to younger and mostly women; Europe continues to give to older individuals (>60); the benefit of vaccination for a life-threatening pandemic is indisputable; maybe instead restrict use to older & further evaluate
Want to put this in perspective. Like breakthroughs after vax, this side effect is EXTREMELY rare & COVID-19 not rare in places like Michigan (where hospitalization rate is turning- will tweet) so think risk-benefit on decisions. Keep calm; we have to get through pandemic too
I think this is a wonderful visualization about the risk-benefit calculus of the J&J vaccine by @WaPo. Look at red dots of 1 in 1.1 million vaccines rare side effect; "By way of comparison, every year about 12 in 100,000 Americans die in a car crash
washingtonpost.com/politics/2021/…
And then finally, I believe committee looking into whether the dose the J&J vaccine used is too high (and AZ vaccine too). Please remember phase I/II trials of escalating doses; sometimes we choose the highest dose when medium/low work as well - see graph
nejm.org/doi/full/10.10…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Monica Gandhi MD, MPH

Monica Gandhi MD, MPH Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MonicaGandhi9

14 Apr
COVID-19 policy blog today cautiously optimistic about turning point near with states who had increased cases/hospitalizations. "In Michigan, testing positivity rates and reproduction numbers are stabilizing or ...falling in many counties"
policylab.chop.edu/blog/covid-19-…
"Our models now forecast declines in reproduction numbers and case incidence over the next four weeks". And importantly for SCHOOLS: "Infections with the B.1.1.7 variant strain grew most quickly for children at the height of the United Kingdom’s winter surge. That, and ..
"rising infections now in youth, has led some to warn the public.. to consider closing schools again in this current resurgence. But our interpretation is far different, and we would advise schools that are doing well to stay the course"..."There is no evidence that the severity
Read 5 tweets
12 Apr
Sobering article on how there will be a wave of disability & death from other chronic diseases after pandemic (happened in 1918 too). Will be tempting to keep testing asymptomatic after vax, but must turn attention to other health conditions after mass vax
medscape.com/viewarticle/94…
White House reports 88,000 overdose deaths during this pandemic (San Francisco has had 3 times as many overdose deaths than those from COVID-19 during pandemic). Another sobering reality of this painful time.
healio.com/news/primary-c…
And great article about @DrLeanaWen about the epidemic of obesity in US & its increase in the pandemic: "concerning study in which 42% of people self-reported gaining weight since the pandemic began; average addition was 29 lb; 10% reported gaining >50lb"
washingtonpost.com/opinions/2021/…
Read 5 tweets
11 Apr
Good news. Vaccines defanging virus. Public data showing reductions in hospitalizations among those who got vax first (older) very prominent. U.S. Total, Last 7 Days Hospital Admissions, 4/9/21, 37,519 vs. 45,003 2/24/21, -17% (7.5k reduction)
healthdata.gov/Health/COVID-1…
Hospitalizations per case (H/c) ratios:
70+ 4/9/21 9,741 vs. 2/24/21, 17,019: -43% (7.4k reduction)
60-69 4/9/21 7,464 vs. 2/24/21, 9,310: -20% (1.8k reduction)
50-59 4/9/21 7,100 vs. 2/24/21 6,677 or +6% (0.4k increase)
40-49 4/9/21 4,587 vs. 2/24/21 3,975 or +15% (0.6k increase
30-39 4/9/21 3,396 vs. 2/24/21 2,885: +18% (0.5k increase)
18-29 4/9/21 2,363 vs. 2/24/21 2,139:+8% (0.2k increase)
Under 18 4/9/21 843 vs. 2/24/21 1,020: -17% (0.2 reduction)- phew
Unknown, 4/9/21 2,120 vs. 2/24/21 1,919:+10% (0.2 increase)
Read 7 tweets
11 Apr
Another study showing re-infection rare after natural infection. "Establishing whether reinfection is typically symptomatic or asymptomatic, whether reinfected individuals are infectious, and expected duration" of immunity from infection vs vax paramount
thelancet.com/journals/lance…
From awesome SIREN study, which is prospective cohort study in staff working in NHS hospitals across UK (giving us great info about vaccine effectiveness too). Lancet asked for "prior evidence" before this study & re-infection up to Nov 15, 2020 rare - 24 documented infections.
25,661 participants with linked data on antibody and PCR included. If had prior infection (documented by antibodies, T cells not measured), re-infection rare. 1859 new infections: 1704 in the negative cohort & 155 reinfections in the positive cohort. Symptoms among re-infections?
Read 6 tweets
9 Apr
We proposed metrics when restrictions could be safely lifted in states- which are1) high rates of vaccination & 2) getting down to 5 hospitalizations per 100,000. Wanted to list where each state is in hospitalization metric (surge vaccine to those highest) washingtonpost.com/outlook/2021/0…
4/3/21 HHS COVID-19 Patient Impact and Hospital Capacity by State Report and COVID Tracking Project (for pandemic peaks):
Total U.S. Total: 15 hospitalizations per 100k; peak of pandemic was 64 per 100k, as of 4/3/21 we are at 23% of the pandemic peak
MI: 34 per 100k; peak of pandemic was 54 per 100k so at 63% of pandemic peak
DC: 33 per 100k; peak was 84 per 100k so at 39% of pandemic peak
NY: 32 per 100k; peak was 123 per 100k so at 26% of pandemic peak
NJ: 31 per 100K; peak was 116 per 100k so at 27% of peak
MD: 27 per 100k
Read 13 tweets
7 Apr
Let's talk B117 and why I don't think this variant is going to deter our progress. What are 3 things you worry about with a variant? 1) Increased transmissibility; 2) Increased virulence; 3) Can escape immunity from your vaccine (or natural infection). Let's take them 1 at a time
1) Increased transmissibility: There is lab data showing higher viral loads with this variant in nose so could be more infectious. However please look at epidemiology on world stage and in U.S. to make your decisions. UK tamped down virus with vaccines with 90% of their strains
being B117 and never saw their dreaded surge once vaccine roll-out started; 2) Israel started rolling out vaccine with 80% of strains being B117, saw surge as we are seeing in some states here (will get to that in min.) but then tamped down with vaccine
pfizer.com/news/press-rel…
Read 22 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!